Literature DB >> 11895921

Anticancer activity of docetaxel in murine salivary gland carcinoma.

Marie P Piechocki1, Fulvio Lonardo, John F Ensley, Tam Nguyen, Harold Kim, George H Yoo.   

Abstract

PURPOSE: The purpose of this study was to evaluate the biological mechanisms of docetaxel (TXT) on salivary gland carcinoma. EXPERIMENTAL
DESIGN: The effects of TXT on a spontaneous murine salivary carcinoma were determined. Proliferation, cell cycle regulation, connexin43 expression, gap-junctional intercellular communication, apoptosis, and Fas receptor (FasR) expression were measured.
RESULTS: We characterized a spontaneous mouse salivary gland carcinoma (SGC1). SGC1 is a poorly differentiated carcinoma that originated from the parotid gland of a BALB/c mouse. SGC1 cells were cultured and found to be immortal past 30 passages. Initially, cells formed tumor nodules in severe combined immunodeficient (SCID) mice. Afterward, SGC1 cells that were subcultured from SCID tumors readily formed colonies in soft agar and were highly tumorigenic in SCID mice and immune-competent BALB/c hosts. Dose response for TXT with respect to growth suppression, G(2)-M cell cycle arrest, and apoptosis was found. Induction of apoptosis by TXT coincided with an increase in cell surface FasR expression. Up-regulation of FasR with lower doses of TXT rendered cells susceptible to FasR agonist antibody-mediated apoptosis. In the absence of TXT, anti-FasR antibodies were completely without effect, suggesting that TXT is critical for priming apoptosis mediated through the Fas pathway. In addition, gap-junctional intercellular communication was augmented by TXT in SGC1 cells concomitant with increased connexin43 expression and membrane localization.
CONCLUSIONS: We have identified several novel targets of TXT that contribute to its antitumor activity in poorly differentiated salivary gland carcinoma. These results suggest that TXT may be appropriate for additional in vivo studies and clinical trials in patients with salivary cancers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11895921

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  5 in total

Review 1.  [Salivary gland carcinomas Part II. Diagnosis and therapy].

Authors:  S Lang; N Rotter; A Lorenzen; S Ihrler; R Eckel; D Hölzel; G Rasp; B Wollenberg; K Sommer
Journal:  HNO       Date:  2005-10       Impact factor: 1.284

2.  Activation of intracellular signaling pathways by the murine cytomegalovirus G protein-coupled receptor M33 occurs via PLC-{beta}/PKC-dependent and -independent mechanisms.

Authors:  Joseph D Sherrill; Melissa P Stropes; Olivia D Schneider; Diana E Koch; Fabiola M Bittencourt; Jeanette L C Miller; William E Miller
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

3.  Docetaxel inhibits bone resorption through suppression of osteoclast formation and function in different manners.

Authors:  Masahiro Takahashi; Toshihide Mizoguchi; Shunsuke Uehara; Yuko Nakamichi; Shuhua Yang; Hiroko Naramoto; Teruhito Yamashita; Yasuhiro Kobayashi; Minoru Yamaoka; Kiyofumi Furusawa; Nobuyuki Udagawa; Takashi Uematsu; Naoyuki Takahashi
Journal:  J Bone Miner Metab       Date:  2008-12-13       Impact factor: 2.626

4.  Potential biomarkers and signaling pathways associated with the pathogenesis of primary salivary gland carcinoma: a bioinformatics study.

Authors:  Zeynab Bayat; Fatemeh Ahmadi-Motamayel; Mohadeseh Salimi Parsa; Amir Taherkhani
Journal:  Genomics Inform       Date:  2021-12-31

Review 5.  Gap junction-mediated cell-to-cell communication in oral development and oral diseases: a concise review of research progress.

Authors:  Wenjing Liu; Yujia Cui; Jieya Wei; Jianxun Sun; Liwei Zheng; Jing Xie
Journal:  Int J Oral Sci       Date:  2020-06-12       Impact factor: 6.344

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.